previous compound ID: 289 next compound
InChIKey: BWHLPLXXIDYSNW-UHFFFAOYSA-N
SMILES: C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "E Matthes" "D Rotin" "GW Carlile" "J Liao" "JW Hanrahan" "J Goepp" "DY Thomas" "R Robert" "SD Macknight"

chemical graph of compound 289





CID is 84003
synonyms found at PubChem are:
Ketorolac tromethamine, Ketorolac tris salt, 74103-07-4, Toradol, Acular, Acular LS, Acular PF, Acuvail, Syntex, Ketorolac (tromethamine salt), Ketorolac trometamol, SPRIX, Acular Preservative Free, Ketorolac tromethamine salt, Ketorolac (Toradol), Lixidol, Dolac, 2-amino-2-(hydroxymethyl)propane-1,3-diol 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, CPD000058461, Acular (TN), (+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), Q-201269, C19H24N2O6, Godek, (+/-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid tris salt, CHEBI:6130, 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), 2-amino-2-(hydroxymethyl)propane-1,3-diol; 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, SMR000058461, Tromethamine ketorolac, SR-01000075948, Toratex, Droal, Ketorolac Rinse, Ketorolac tromethamine [USAN], Tora-Dol, Ketorolac tromethamine [USAN:USP], 2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, C15H13NO3.C4H11NO3, BPPC, ketorolac; tris buffer, Spectrum_001578, Ketorolac tromethamine ophthalmic solution, Prestwick0_000929, Prestwick1_000929, Prestwick2_000929, Prestwick3_000929, Spectrum2_001598, Spectrum3_001975, Spectrum4_000215, Spectrum5_001273, AC1L36LM, SCHEMBL5036, Lopac0_000676, BSPBio_000838, BSPBio_003575, KBioGR_000849, KBioSS_002058, Ketorolac tromethamine (USP), MLS000069689, MLS001401455, MLS002222310, DivK1c_000836, SPECTRUM1503925, SPBio_001596, SPBio_003017, BPBio1_000922, CHEMBL1201124, CTK8G0438, HMS502J18, KBio1_000836, KBio2_002058, KBio2_004626, KBio2_007194, KBio3_002953, KS-00000XLJ, ROX-828, ROX-888, BWHLPLXXIDYSNW-UHFFFAOYSA-N, MolPort-003-666-507, NINDS_000836, Acular;Ketorolac tris salt;Toradol, HMS1570J20, HMS1922K22, HMS2051P06, HMS2093M05, HMS2097J20, HMS2235N13, HMS3262G13, HMS3373M06, HMS3393P06, HMS3655E15, HMS3714J20, Pharmakon1600-01503925, BCP02917, HY-B0138, (+/-)-Ketorolac Tromethamine Salt, Tox21_500676, ABP001027, BG0547, CCG-39376, CK0012, MFCD00887595, NSC758637, AKOS024386301, API0003085, BCP9000811, CCG-101006, CS-1933, LP00676, NC00256, NSC-758637, RL04801, IDI1_000836, NCGC00016159-02, NCGC00016159-03, NCGC00016159-04, NCGC00094036-01, NCGC00094036-02, NCGC00094036-03, NCGC00261361-01, 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+/-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol(1:1), AN-37166, AS-15193, O440, SAM001246596, BCP0726000301, Ketorolac tris salt, >=99%, crystalline, AB2000191, LS-139095, EU-0100676, FT-0630829, K0053, ST51037313, D00813, K 1136, 103K074, C-21261, SR-01000946595, SR-01000075948-1, SR-01000075948-6, SR-01000075948-8, SR-01000946595-1, F0001-2390, Ketorolac Trometamol 1.0 mg/ml in Methanol (as free acid), Ketorolac trometamol, European Pharmacopoeia (EP) Reference Standard, Ketorolac Tromethamine, United States Pharmacopeia (USP) Reference Standard, Ketorolac trometamol for peak identification, European Pharmacopoeia (EP) Reference Standard, Ketorolac Tromethamine, Pharmaceutical Secondary Standard; Certified Reference Material, 5-(phenylcarbonyl)-2,3-dihydropyrrolizinecarboxylic acid, 2-amino-2-(hydroxyme thyl)propane-1,3-diol, MolPort-005-934-838, HMS3649A22, AKOS015961616, AC-23357, A838010, [2-(hydroxymethyl)-1,3-bis(oxidanyl)propan-2-yl]azanium; 5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylate, 1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate; [1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]ammonium